Correlation Between CEOTRONICS (CEKSG) and SIMCERE PHARMAC

Can any of the company-specific risk be diversified away by investing in both CEOTRONICS (CEKSG) and SIMCERE PHARMAC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CEOTRONICS (CEKSG) and SIMCERE PHARMAC into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between CEOTRONICS and SIMCERE PHARMAC GRP, you can compare the effects of market volatilities on CEOTRONICS (CEKSG) and SIMCERE PHARMAC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CEOTRONICS (CEKSG) with a short position of SIMCERE PHARMAC. Check out your portfolio center. Please also check ongoing floating volatility patterns of CEOTRONICS (CEKSG) and SIMCERE PHARMAC.

Diversification Opportunities for CEOTRONICS (CEKSG) and SIMCERE PHARMAC

0.67

Correlation Coefficient

CEOTRONICS (CEKSG)  SIMCERE PHARMAC

Poor diversification

The 3 months correlation between CEOTRONICS and SIMCERE is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding CEOTRONICS and SIMCERE PHARMAC GRP in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SIMCERE PHARMAC GRP and CEOTRONICS (CEKSG) is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CEOTRONICS are associated (or correlated) with SIMCERE PHARMAC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SIMCERE PHARMAC GRP has no effect on the direction of CEOTRONICS (CEKSG) i.e., CEOTRONICS (CEKSG) and SIMCERE PHARMAC go up and down completely randomly.

Pair Corralation between CEOTRONICS (CEKSG) and SIMCERE PHARMAC

Assuming the 90 days trading horizon CEOTRONICS is expected to generate 1.5 times more return on investment than SIMCERE PHARMAC. However, CEOTRONICS (CEKSG) is 1.5 times more volatile than SIMCERE PHARMAC GRP. It trades about 0.06 of its potential returns per unit of risk. SIMCERE PHARMAC GRP is currently generating about -0.15 per unit of risk. If you would invest  590.00  in CEOTRONICS on October 15, 2024 and sell it today you would earn a total of  10.00  from holding CEOTRONICS or generate 1.69% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

CEOTRONICS  vs.  SIMCERE PHARMAC GRP

CEOTRONICS (CEKSG)

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in CEOTRONICS are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, CEOTRONICS (CEKSG) unveiled solid returns over the last few months and may actually be approaching a breakup point.

SIMCERE PHARMAC GRP

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in SIMCERE PHARMAC GRP are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, SIMCERE PHARMAC reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with CEOTRONICS (CEKSG) and SIMCERE PHARMAC

The main advantage of trading using opposite CEOTRONICS (CEKSG) and SIMCERE PHARMAC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CEOTRONICS (CEKSG) position performs unexpectedly, SIMCERE PHARMAC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SIMCERE PHARMAC will offset losses from the drop in SIMCERE PHARMAC's long position.

The idea behind CEOTRONICS and SIMCERE PHARMAC GRP pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.